Free Trial

Surmodics (SRDX) News Today

→ Nvidia’s Quiet $1 Trillion Pivot (From Weiss Ratings) (Ad)
Free SRDX Stock Alerts
$41.86
-0.09 (-0.21%)
(As of 06/10/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends
June 10 at 7:00 AM | businesswire.com
Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.
June 10 at 1:58 AM | americanbankingnews.com
Zacks Research Weighs in on Surmodics, Inc.'s Q3 2025 Earnings (NASDAQ:SRDX)
June 8 at 1:40 AM | americanbankingnews.com
Surmodics (NASDAQ:SRDX) Receives New Coverage from Analysts at StockNews.com
June 5, 2024 | marketbeat.com
Surmodics (NASDAQ:SRDX) Sees Unusually-High Trading Volume
Surmodics (NASDAQ:SRDX) Sees Large Volume Increase
June 3, 2024 | americanbankingnews.com
Zacks Research Comments on Surmodics, Inc.'s Q1 2025 Earnings (NASDAQ:SRDX)
June 1, 2024 | americanbankingnews.com
Surmodics (NASDAQ:SRDX) Stock Rating Reaffirmed by Barrington Research
June 1, 2024 | americanbankingnews.com
Q3 2025 EPS Estimates for Surmodics, Inc. Lifted by Analyst (NASDAQ:SRDX)
May 31, 2024 | marketbeat.com
Zacks Research Research Analysts Raise Earnings Estimates for Surmodics, Inc. (NASDAQ:SRDX)
Surmodics, Inc. (NASDAQ:SRDX - Free Report) - Research analysts at Zacks Research boosted their Q3 2025 earnings per share (EPS) estimates for shares of Surmodics in a report released on Wednesday, May 29th. Zacks Research analyst D. Dey now forecasts that the company will earn $0.11 per share fo
May 30, 2024 | marketbeat.com
Surmodics (NASDAQ:SRDX) Downgraded to "Hold" at StockNews.com
StockNews.com cut shares of Surmodics from a "buy" rating to a "hold" rating in a research note on Thursday.
May 30, 2024 | marketbeat.com
Surmodics (NASDAQ:SRDX) Sees Strong Trading Volume
Surmodics (NASDAQ:SRDX) Sees Strong Trading Volume
May 30, 2024 | marketbeat.com
Surmodics (NASDAQ:SRDX) Receives "Market Perform" Rating from Barrington Research
Barrington Research reiterated a "market perform" rating on shares of Surmodics in a report on Thursday.
May 29, 2024 | prnewswire.com
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc.
May 29, 2024 | marketbeat.com
Surmodics' (SRDX) "Hold" Rating Reaffirmed at Lake Street Capital
Lake Street Capital restated a "hold" rating and set a $43.00 price objective on shares of Surmodics in a report on Wednesday.
May 29, 2024 | marketwatch.com
Surmodics Shares Up in Premarket on $627M Go-Private Deal With GTCR
May 29, 2024 | msn.com
Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday
May 29, 2024 | markets.businessinsider.com
GTCR To Acquire Surmodics - Quick Facts
May 29, 2024 | tmcnet.com
SRDX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surmodics, Inc. Is Fair to Shareholders
May 29, 2024 | msn.com
Surmodics jumps 18% on acquisition by GTCR
May 29, 2024 | benzinga.com
Why Is Medical Coating Specialist Surmodics Trading Higher On Wednesday?
May 29, 2024 | marketbeat.com
Surmodics (NASDAQ:SRDX) Sets New 1-Year High at $42.36
Surmodics (NASDAQ:SRDX) Hits New 52-Week High at $42.36
May 29, 2024 | prnewswire.com
Shareholder Alert: Ademi LLP investigates whether Surmodics, Inc. has obtained a Fair Price for its Public Shareholders
May 29, 2024 | businesswire.com
Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million
May 24, 2024 | marketbeat.com
Surmodics, Inc. (NASDAQ:SRDX) Forecasted to Earn Q3 2024 Earnings of ($0.31) Per Share
Surmodics, Inc. (NASDAQ:SRDX - Free Report) - Stock analysts at Zacks Research lowered their Q3 2024 EPS estimates for Surmodics in a research report issued on Wednesday, May 22nd. Zacks Research analyst D. Dey now expects that the company will earn ($0.31) per share for the quarter, down from th
May 23, 2024 | marketbeat.com
FY2026 EPS Estimates for Surmodics, Inc. (NASDAQ:SRDX) Raised by Analyst
Surmodics, Inc. (NASDAQ:SRDX - Free Report) - Analysts at Zacks Research raised their FY2026 EPS estimates for Surmodics in a research report issued to clients and investors on Wednesday, May 22nd. Zacks Research analyst D. Dey now anticipates that the company will post earnings of $0.32 per shar
May 22, 2024 | marketbeat.com
Panagora Asset Management Inc. Boosts Stock Position in Surmodics, Inc. (NASDAQ:SRDX)
Panagora Asset Management Inc. boosted its holdings in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 109.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 44,664 shares of the company's stock after acquiring an additional 23,379 shares during t
May 22, 2024 | marketbeat.com
Surmodics (NASDAQ:SRDX) Share Price Crosses Above Two Hundred Day Moving Average of $32.01
Surmodics (NASDAQ:SRDX) Shares Pass Above Two Hundred Day Moving Average of $32.01
May 21, 2024 | finance.yahoo.com
Surmodics, Inc.'s (NASDAQ:SRDX) Intrinsic Value Is Potentially 96% Above Its Share Price
May 4, 2024 | finance.yahoo.com
Surmodics, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
May 2, 2024 | marketbeat.com
Surmodics (NASDAQ:SRDX) Rating Reiterated by Barrington Research
Barrington Research reissued an "outperform" rating and issued a $71.00 price objective on shares of Surmodics in a research note on Thursday.
May 2, 2024 | marketbeat.com
Surmodics (NASDAQ:SRDX) Releases Earnings Results, Beats Expectations By $0.43 EPS
Surmodics (NASDAQ:SRDX - Get Free Report) released its quarterly earnings data on Wednesday. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of ($0.36) by $0.43. Surmodics had a return on equity of 8.06% and a net margin of 3.99%. The business had revenue of $31.96 million during the quarter, compared to analysts' expectations of $28.79 million. During the same quarter last year, the business posted ($0.40) EPS.
May 2, 2024 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: CVS Health (CVS) and SurModics (SRDX)
May 2, 2024 | finance.yahoo.com
Surmodics Inc (SRDX) Q2 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ...
May 1, 2024 | uk.finance.yahoo.com
Surmodics, Inc. (SRDX) stock price, news, quote & history – Yahoo Finance
May 1, 2024 | markets.businessinsider.com
SurModics Outperforms with Raised Guidance and Strong Product Momentum: Buy Rating Reaffirmed
May 1, 2024 | marketbeat.com
Surmodics (NASDAQ:SRDX) PT Lowered to $43.00
Needham & Company LLC lowered their target price on shares of Surmodics from $47.00 to $43.00 and set a "buy" rating for the company in a research note on Wednesday.
May 1, 2024 | investorplace.com
SRDX Stock Earnings: Surmodics Beats EPS, Beats Revenue for Q2 2024
May 1, 2024 | marketbeat.com
Surmodics (NASDAQ:SRDX) Issues FY 2024 Earnings Guidance
Surmodics (NASDAQ:SRDX) updated its FY 2024 earnings guidance. The company provided EPS guidance of -0.670--0.470 for the period, compared to the consensus estimate of -0.940. The company also issued revenue guidance of $118.0 millionillion-$120.0 millionillion, compared to the consensus estimate of $119.7 millionillion.
May 1, 2024 | businesswire.com
Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
April 30, 2024 | markets.businessinsider.com
SurModics earnings: here's what Wall Street expects
April 30, 2024 | finance.yahoo.com
Can the 4 Medical Device Stocks Hit Targets This Earnings Season?
April 24, 2024 | marketbeat.com
Surmodics (SRDX) Set to Announce Quarterly Earnings on Wednesday
Surmodics (NASDAQ:SRDX) will be releasing earnings before the market opens on Wednesday, May 1, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=381142)
April 19, 2024 | businesswire.com
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
April 17, 2024 | finance.yahoo.com
Will SurModics (SRDX) Report Negative Q2 Earnings? What You Should Know
April 16, 2024 | marketbeat.com
Surmodics (NASDAQ:SRDX) Rating Increased to Strong-Buy at StockNews.com
StockNews.com upgraded shares of Surmodics from a "buy" rating to a "strong-buy" rating in a report on Tuesday.
April 13, 2024 | finance.yahoo.com
Investors in Surmodics (NASDAQ:SRDX) have unfortunately lost 54% over the last three years
April 11, 2024 | marketbeat.com
Q1 2025 Earnings Estimate for Surmodics, Inc. Issued By Zacks Research (NASDAQ:SRDX)
Surmodics, Inc. (NASDAQ:SRDX - Free Report) - Investment analysts at Zacks Research increased their Q1 2025 earnings per share (EPS) estimates for shares of Surmodics in a research report issued to clients and investors on Tuesday, April 9th. Zacks Research analyst D. Dey now expects that the com
April 10, 2024 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: Genprex (GNPX) and SurModics (SRDX)
April 10, 2024 | marketbeat.com
Surmodics' (SRDX) "Buy" Rating Reiterated at Needham & Company LLC
Needham & Company LLC restated a "buy" rating and issued a $47.00 price objective on shares of Surmodics in a report on Wednesday.
April 10, 2024 | marketbeat.com
Q4 2025 EPS Estimates for Surmodics, Inc. Boosted by Zacks Research (NASDAQ:SRDX)
Surmodics, Inc. (NASDAQ:SRDX - Free Report) - Stock analysts at Zacks Research lifted their Q4 2025 EPS estimates for Surmodics in a note issued to investors on Tuesday, April 9th. Zacks Research analyst D. Dey now forecasts that the company will earn $0.66 per share for the quarter, up from thei
March 23, 2024 | finance.yahoo.com
Should You Think About Buying Surmodics, Inc. (NASDAQ:SRDX) Now?
Get Surmodics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter.

The #1 Crypto That You Don’t Own… Yet (Ad)

There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.

Click here for all the details…

SRDX Media Mentions By Week

SRDX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SRDX
News Sentiment
▼
0.85

0.75
▲
Average
Medical
News Sentiment

SRDX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SRDX Articles
This Week
▼
7

2
▲
SRDX Articles
Average Week

Get Surmodics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:SRDX) was last updated on 6/11/2024 by MarketBeat.com Staff

From Our Partners
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored
DON’T buy gold until you read this
If you're an American who understands that your money is rotting away as you read this email… Then this is ...
Sasco Gold LLC | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
Hurry! Buy this stock before the Robinhood traders do!
Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...
Traders Agency | Sponsored
Moonshot Coins for the Current Crypto Run
Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...
Crypto 101 Media | Sponsored
The Only Energy Play You Should Be Looking At
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored